![]() The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected in China in December 2019. Multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). ![]() It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms. The included studies defined long-COVID as ranging from 14 to 110 days post-viral infection. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included (age 17–87 years). A total of 18,251 publications were identified, of which 15 met the inclusion criteria. After effects of covid software#For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. LitCOVID and Embase were searched to identify articles with original data published before the 1st of January 2021, with a minimum of 100 patients. This systematic review and meta-analysis aims to identify studies assessing the long-term effects of COVID-19. After effects of covid how to#Over the coming months, determining both the real incidence of after-effects and how to treat them is of high importance, in order to understand the full impact of pneumonia caused by COVID-19 in patients.Īuthors: Jacobo Sellarés, director of the Interstitial Lung Disease Working Group, and Oriol Sibila, Head of Department at the Hospital Respiratory Care.COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. ![]() At the pulmonary level, it is known that a significant percentage of patients who have had a serious form of the illness present changes to respiratory function after three months of being discharged from hospital. ![]() A high number of cases have been documented with persistent symptoms following the acute phase, without any clear relation to the severity of the illness. In conclusion, the mid- and long-term after effects of COVID-19 are still not well understood. Although the full impact of the lesions is currently unknown, various centres are monitoring these patients to be able to detect the potential development of pulmonary fibrosis early, including post-COVID consultation at Hospital Clínic. The current hypothesis is that these lesions are a result of the inflammation caused by the virus itself, along with the consequences of mechanical ventilation in patients who require intubation. These can be precursors to pulmonary fibrosis. Pulmonary lesions can be observed in x-ray images of some patients admitted due to COVID. One of the scientific community’s main concerns regarding the potential after-effects of COVID-19 infection is the development of pulmonary fibrosis. Various investigations in this field, which are still being carried out, will determine the real impact of the after-effects of this disease, especially those that persist in the mid- and long-term, in other words, 6 and 12 months after the serious illness caused by COVID. In the Pneumocovid study, which involved more than 200 patients admitted to Hospital Clínic with serious COVID-19, approximately 25% of patients presented changes to respiratory function three months after being discharged from hospital. However, the study was carried out on a small group of patients, with all the limitations this involves. It is observed that 40% display changes to respiratory function a month after discharge, although the large majority of patients can carry out their day-to-day activities with no restrictions. ![]() One study described that more than half of patients who had to be admitted to hospital due to the SARS-CoV-2 virus continued to present symptoms two months after the start of the illness, with fatigue and dyspnoea (a feeling of shortness of breath) being the most common.Īt the pulmonary level, a recent article analyses patients discharged from intensive care units after suffering a serious illness. Currently, there is not enough reliable data on the mid- and long-term consequences of pneumonia caused by COVID-19. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |